EP Patent
EP0415564A2 — Use of prostanoic acid derivaties for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine
Assigned to Ueno Seiyaku Oyo Kenkyujo KK · Expires 1991-03-06 · 35y expired
What this patent protects
A use of a prostanoic acid derivative for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine.
USPTO Abstract
A use of a prostanoic acid derivative for the manufacture of a medicament for improvement of excretion of nonprotein nitrogen into the intestine.
Drugs covered by this patent
- Amitiza (LUBIPROSTONE) · Sucampo Pharma Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.